2026-04-11T08:13:05Z
https://pub.unibl.org/oai
oai:pub.unibl.org:23022
2025-12-10T04:43:30Z
Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group
/unibl/author/Justyna Kowalska
/unibl/author/Marta Vasyliev
/unibl/author/Antonios Harxhi
/unibl/author/Ladislav Fleischhans
/unibl/author/Silvio Antoniak
/unibl/author/David Gokengin
/unibl/author/Ahmed Vassilenko
/unibl/author/Kerstin Kase
/unibl/author/Raimonda Matulionyte
/unibl/author/Antonios Papadopoulus
/unibl/author/Nino Rukhadze
/unibl/author/Botond Lakatos
/unibl/author/Gordana Dragović-Lukić
/unibl/author/David Jilich
https://www.unibl.org/sr-lat/fis/zaposlen/3299-antonija-verhaz
/unibl/author/Antonija Verhaz
/unibl/author/Josip Begovac
/unibl/author/Agata Skrzat-Klapaczyńska
/unibl/author/Caroline Oprea
2022-07
Conference Paper
text
/unibl/sci/idNaucniRad:29823
https://dx.doi.org/A-AIDS-2022-11249
https://med.unibl.org
AIDS 2022 Conference
https://aids2022.abstractserver.com/abstracts/#/abstract/11249/preview 2/3 Conclusions: In a cohort of PLWH and COVID-19 from Central and Eastern Europe almost 20% were prescribed repurposed drugs. Symptomatic patients, with confirmed SARS-CoV-2 infection and from non-EU country were more likely to receive repurposed drug. Interestingly hospitalized patients were as likely to receive treatment as ambulatory patients. This is a worrying trend as most patients were with mild COVID-19 but on ART with a risk of drug-drug interactions. Ethical research declaration: * Yes Did you receive mentoring for this abstract through the AMP?: No 1. I confirm that I submit this abstract on behalf of all authors.: * Yes 2.I agree to the resubmission policy: * No 3. I agree to the conference embargo policy: * Yes 4. Submission of your abstract constitutes your consent to publication: * Yes 5. I understand that all scholarship requests must be made by the presenting author through the scholarship section of the IAS profile by completing a scholarship application form by 31 January 2022, 23:59 CET.: * Yes 6. I understand that this submitted abstract may be shared with the IAS HIV Programmes team for potential use in sessions that will be organized around the conference:
J. Kowalska, M. Vasyliev, A. Harxhi, L. Fleischhans, S. Antoniak, D. Gokengin, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, B. Lakatos, G. Dragović-Lukić, D. Jilich, A. Verhaz, A. Verhaz, J. Begovac, A. Skrzat-Klapaczyńska, C. Oprea, Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group, Jul, 2022